New insights on premature ejaculation: a review of definition, classification, prevalence and treatment

被引:49
作者
Serefoglu, Ege C. [1 ]
Saitz, Theodore R. [1 ]
机构
[1] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA
关键词
definition; ejaculatory disorders; epidemiology; premature ejaculation; sexual dysfunction; treatment; PLACEBO-CONTROLLED MULTICENTER; SEROTONIN REUPTAKE INHIBITORS; ORALLY DISINTEGRATING TABLET; RANDOMIZED DOUBLE-BLIND; MALE SEXUAL DYSFUNCTION; HYALURONIC-ACID GEL; HISTORICAL DSM-III; ERECTILE DYSFUNCTION; DRUG-TREATMENT; INTERNATIONAL SOCIETY;
D O I
10.1038/aja.2012.108
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
There are ongoing debates about the definition, classification and prevalence of premature ejaculation (PE). The first evidence-based definition of PE was limited to heterosexual men with lifelong PE who engage in vaginal intercourse. Unfortunately, many patients with the complaint of PE do not meet these criteria. However, these men can be diagnosed as one of the PE subtypes, namely acquired PE, natural variable PE or premature-like ejaculatory dysfunction. Nevertheless, the validity of these subtypes has not yet been supported by evidence. The absence of a universally accepted PE definition and lack of standards for data acquisition have resulted in prevalence studies that have reported conflicting rates. The very high prevalence of 20%-30% is probably due to the vague terminology used in the definitions at the time when such surveys were conducted. Although many men may complain of PE when questioned for a population-based prevalence study, only a few of them will actively seek treatment for their complaint, even though most of these patients would define symptoms congruent with PE. The complaints of acquired PE patients may be more severe, whereas complaints of patients experiencing premature-like ejaculatory dysfunction seem to be least severe among men with various forms of PE. Although numerous treatment modalities have been proposed for management of PE, only antidepressants and topical anaesthetic creams have currently been proven to be effective. However, as none of the treatment modalities have been approved by the regulatory agencies, further studies must be carried to develop a beneficial treatment strategy for PE. Asian Journal of Andrology (2012) 14, 822-829; doi: 10.1038/aja.2012.108; published online 15 October 2012
引用
收藏
页码:822 / 829
页数:8
相关论文
共 114 条
[101]   Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I - Validity of DSM-IV-TR [J].
Waldinger, Marcel D. ;
Schweitzer, Dave H. .
JOURNAL OF SEXUAL MEDICINE, 2006, 3 (04) :682-692
[102]   Recent advances in the classification, neurobiology and treatment of premature ejaculation [J].
Waldinger, Marcel D. .
SEXUAL DYSFUNCTION: THE BRAIN-BODY CONNECTION, 2008, 29 :50-69
[103]  
Waldinger MD, 2008, J SEX MED, V5, P966, DOI 10.1111/j.1743-6109.2008.00633.x
[104]   The majority of men with lifelong premature ejaculation prefer daily drug treatment: An observation study in a consecutive group of Dutch men [J].
Waldinger, Marcel D. ;
Zwinderman, Aeilko H. ;
Olivier, Berend ;
Schweitzer, Dave H. .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04) :1028-1037
[105]   Premature ejaculation - Definition and drug treatment [J].
Waldinger, Marcel D. .
DRUGS, 2007, 67 (04) :547-568
[106]   Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis [J].
Waldinger, MD ;
Zwinderman, AH ;
Schweitzer, DH ;
Olivier, B .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (04) :369-381
[107]   Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment [J].
Waldinger, MD .
WORLD JOURNAL OF UROLOGY, 2005, 23 (02) :102-108
[108]   A multinational population survey of intravaginal ejaculation latency time [J].
Waldinger, MD ;
Quinn, P ;
Dilleen, M ;
Mundayat, R ;
Schweitzer, DH ;
Boolell, M .
JOURNAL OF SEXUAL MEDICINE, 2005, 2 (04) :492-497
[109]   Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline [J].
Waldinger, MD ;
Hengeveld, MW ;
Zwinderman, AH ;
Olivier, B .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) :274-281
[110]   The neurobiological approach to premature ejaculation [J].
Waldinger, MD .
JOURNAL OF UROLOGY, 2002, 168 (06) :2359-2367